Close Menu

NEW YORK – The European Commission last week issued a decision to designate Dekra as a notified body for overseeing compliance with the new In Vitro Diagnostic Regulation.

The Berlin-based company is the first to be designated and more NBs expect they will be designated by year end. The EC published its decision concerning Dekra on Oct. 10.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.